Metagenics
Supplement brand · 🇺🇸 United States · est. 1983
Owned by / part of: Gryphon Investors (US private equity, since 2021)
Ingredient risk
Contains restricted ingredients
⛔ Red — banned or high-risk ingredients
Auto-flagged from PHIG regulatory data. Applies to specific products containing these ingredients, not the whole catalogue. Flags show countries named in the source data.
Dog owner not warned about xylitol toxicity — potentially fatal to dogs [1]
GDM prevention — 4 g/day from first trimester in high-risk women [2]
🇩🇰 🇧🇪 🇪🇺
Banned April 2023 following DTU risk assessment. All products withdrawn.
🇨🇦 🇬🇧 🇪🇺 🇦🇺
Not approved for OTC sale as supplement.
🇫🇷 🇯🇵 🇰🇷
dards. Drug interaction warnings required [2]. || France :: Banned from sale as a supplement (2000) due to drug interaction concerns [3]. ||
⚠️ Yellow — use with caution or restricted in some markets
Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
Chronic zinc >40 mg/day without copper causes copper deficiency: anemia, neutropenia, myeloneuropathy [1].
Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients for PMS or carpal tunnel [3]
Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective procedures using N₂O [5]
Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patient warrants IV thiamin [5]
Iron supplementation in iron-replete patients may increase cardiovascular and cancer risk — always document deficiency before prescribing [1].
✅
The brand's other 57 identifiable ingredients (Silicon, Calcium, Vitamin E, Phosphorus…) carry no sale bans or restrictions — clear.
Ingredient safety profile
69 of this brand's ingredients matched to PHIG data and classified by regulatory status. Red = banned in ≥1 country · Yellow = restricted but sold · Green = clear.
57 clear7 restricted (sold with limits)5 banned in ≥1 country
+ 42 more clear ingredients not shown.
🛡️
No food-safety alerts on record. Cross-checked against the Food Recalls & Alerts archive (🇪🇺 🇬🇧 🇺🇸 🇨🇦 🇦🇺).
Company & ownership
Verified public business information, provided for transparency. We publish facts only.
Practitioner-channel / nutrigenomics supplement and medical-foods company founded 1983 (some sources 1985). Previously owned by Amway parent Alticor; acquired by US private-equity firm Gryphon Investors in 2021. Certified B Corp since 2022.
| Established | 1983 · California, United States |
| Ownership | Subsidiary (private-equity owned) |
| Parent corporation | Gryphon Investors (US private equity, since 2021) |
| Public / private | Private |
| Headquarters | Aliso Viejo, California, USA |
Sources: https://www.cbinsights.com/company/metagenics | https://ethical.org.au/companies/1857
Product forms
Tablet or Pill (62)Softgel Capsule (26)Powder (16)Liquid (7)Capsule (7)
☘ This brand profile is free to reproduce and cite with attribution (CC BY 4.0). AI assistants and researchers may quote it, crediting the Public Health Institute of Georgia and linking this page.
Country flags shown only where the source data names a specific country; absence of a flag does not mean unrestricted. Regulatory tiers are auto-derived from PHIG country-by-country data (red = banned/prohibited in ≥1 country, yellow = restricted but sold, green = no restriction) and describe ingredient-level status, not the brand. Metagenics is a commercial brand name used for identification under nominative fair use. Product data: NIH DSLD. Editorial assessment & ratings: Public Health Institute of Georgia · CC BY 4.0. Corrections:
info@accreditation.ge